Teva

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) CEO Richard Francis believes that the Israeli drug-maker is entering an era of growth, is bullish about its ability to achieve good value for the sale of its…

For the first time since 2016, Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) enlarged its workforce during 2023. The Israeli company had 36,472 employees at the end of 2023, up 1,347 or 3.8% from 2022,…

More and more analysts are expressing confidence in the stock of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA). Data from "The Wall street Journal" shows that just three months ago the analysts' consensus…

At the end of 2023, Israeli insurance and finance group The Phoenix Holdings' stake in Teva was 5.4%. Insurance and finance group The Phoenix Holdings (TASE: PHOE)…

After just over a year in the job, Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) CEO Richard Francis can afford a smile. For the first time in three and a half years the Israeli pharmaceuticals company is…

Israel's most profitable company on Wall Street in 2023 is somewhat surprising. Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) recorded a non-GAAP net profit of $1.76 billion in the first nine month of 2023…

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) and Israeli company Biolojic Design have signed a collaboration agreement. Teva will complete development of Biolojic's antibody-based therapy for the treatment…

Swiss bank UBS has upgraded its recommendation for Israeli drugmaker Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) to Buy from Neutral. UBs has also raised its price target for Teva from $11 to $13. The…

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) and Royalty Pharma plc (Nasdaq: RPRX), announced today a collaboration to accelerate the clinical research program for Teva’s olanzapine LAI (TEV-‘749)…

JERUSALEM (Reuters) -Teva Pharmaceutical Industries reported slightly higher third-quarter profit, helped by sales of its Austedo treatment for Huntington's Disease, and said production in Israel was unaffected by the country's war with…